Crossmark

Minimal contribution of the hepatic uptake transporter OATP1B1 to the inter-individual variability in SN-38 pharmacokinetics in cancer patients without severe renal failure

Crossref DOI link: https://doi.org/10.1007/s00280-021-04314-1

Published Online: 2021-06-11

Published Print: 2021-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tsuboya, Ayako

Kubota, Yutaro

Ishida, Hiroo

Ohkuma, Ryotaro

Ishiguro, Tomoyuki

Hirasawa, Yuya

Ariizumi, Hirotsugu

Tsunoda, Takuya

Sasaki, Yasutsuna

Matsumoto, Natsumi

Kondo, Yusuke

Tomoda, Yukana

Kusuhara, Hiroyuki

Fujita, Ken-ichi https://orcid.org/0000-0002-1575-6690
License Information

Text and Data Mining valid from 2021-06-11

Version of Record valid from 2021-06-11
More Information

Article History

Received: 5 April 2021

Accepted: 5 June 2021

First Online: 11 June 2021

Declarations

:

: We have no conflict of interest to declare.

: The study protocol was approved by the Institutional Review Board of Showa University. The study was registered on University Hospital Medical Information Network-Clinical Trials Registry Japan (UMIN000023783).

: All patients gave written informed consent for the use of their peripheral blood samples and medical information for research purposes.

: All patients gave written informed consent regarding publishing their data.

Document is current

Any future updates will be listed below